YouTube2Text

The AI Trade Isn't Dead (Here Are 5 Stocks to Buy) — Transcript

by Being Exponential with Luke Lango · 5,224 words · 773 segments · language en · Watch on YouTube

Full transcript

  1. 0:00The AI data center trade is
  2. 0:01transitioning, not ending. The
  3. 0:04transition is painful and it may not be
  4. 0:06over. Maybe more shoes to drop if you
  5. 0:09well, more legs lower if you well, but
  6. 0:12eventually we are going to bottom and
  7. 0:13when we do bottom, I think it's going to
  8. 0:15be a massive rebound rally on the other
  9. 0:17side as the market adjusts to the new
  10. 0:18normal of stable but still high capital
  11. 0:22spending plans from the hyperscalers.
  12. 0:24>> Hello and welcome to Bang Exponential.
  13. 0:26Today we're going to be covering our
  14. 0:27five stocks of the week. Uh so Luke, we
  15. 0:29had a almost broad spectrum of stocks
  16. 0:32here this week. Let's start off with
  17. 0:34Cloudflare, NET.
  18. 0:38>> Yeah, bro. So I think that the the setup
  19. 0:40for the market has dramatically changed
  20. 0:42over the last week. Um the price action
  21. 0:45has been very violent and some major
  22. 0:48technical levels are are breaking and
  23. 0:50fundamental conditions have changed too.
  24. 0:53And so I think in response to that, you
  25. 0:56know, our
  26. 0:57thesis has been AI with AI, which has
  27. 1:01been expressed through being all in with
  28. 1:04the AI supply chain stocks, the uh
  29. 1:07nebulas of the world, the Marvels of the
  30. 1:09world, the Broadcoms of the world, the
  31. 1:10AMDs of the world, the Nvidias of the
  32. 1:12world, the recent networks of the world,
  33. 1:13etc etc.
  34. 1:15That trade is under significant
  35. 1:17pressure, has been under significant
  36. 1:18pressure and it looks like the pressure
  37. 1:20there could persist for a little while
  38. 1:23longer. I don't think the trade is dead
  39. 1:24by any means. We'll talk about that in
  40. 1:25our macro podcast, but I do think that
  41. 1:28that there is more pressure there uh in
  42. 1:31the short term and that things could get
  43. 1:33worse before they get better. So this
  44. 1:35episode I want to focus on stocks that I
  45. 1:37think can
  46. 1:39weather
  47. 1:41that storm really well. There are parts
  48. 1:43of the market that despite the broader
  49. 1:46weakness and despite the specific
  50. 1:47weakness in the AI trade have done
  51. 1:50pretty well in the last month, in the
  52. 1:53last three months, in the last six
  53. 1:55months. And these are the stocks that I
  54. 1:58think investors can shelter in during
  55. 2:01this very turbulent period for the AI
  56. 2:04trade. And so one of them is Cloudflare.
  57. 2:08Now Cloudflare obviously that's the
  58. 2:10cybersecurity play. We've talked about
  59. 2:12cyber before when we had JR on the
  60. 2:13podcast. We didn't talk about Cloudflare
  61. 2:16specifically, but that's probably my
  62. 2:18favorite name in the entire cyberspace
  63. 2:20cuz they're basically the the doorman
  64. 2:23for the internet. So that anytime
  65. 2:26there's traffic on the internet internet
  66. 2:27or somebody wants to go on a website,
  67. 2:29they're sort of the doorman allowing
  68. 2:31traffic into that website.
  69. 2:34That's really important in the era of
  70. 2:36agentic AI because internet traffic is
  71. 2:41one going to grow dramatically. We've
  72. 2:44already seen that because it's not users
  73. 2:47anymore, it's agents and every user can
  74. 2:50have 10 20 30 40 50 hundreds of agents
  75. 2:54that are constantly running throughout
  76. 2:56the internet. So internet traffic grows
  77. 2:58exponentially in the era of agentic AI.
  78. 3:01And two, these agents have different
  79. 3:04behaviors than humans. And they have
  80. 3:08different intentions and is it a rogue
  81. 3:11agent? Is it a planned agent? What
  82. 3:13what's the intention behind the action
  83. 3:14that it's doing? So the sort of
  84. 3:16behavioral analysis of the doorman also
  85. 3:20has to fundamentally change. And so I
  86. 3:22think those are two massive tailwinds
  87. 3:25for company that protects websites, that
  88. 3:28protects the internet if you will. And
  89. 3:31that's Cloudflare. Cloudflare is the
  90. 3:33king of this space. They are the big
  91. 3:35dog. They are a massive growth company
  92. 3:38and I really like the setup here because
  93. 3:40they just reported earnings.
  94. 3:42Earnings were fantastic. This is a stock
  95. 3:44that you can see here in the chart. It
  96. 3:46pulled back pretty dramatically, right?
  97. 3:47This is a stock that topped out right
  98. 3:49around 350 uh in late September, early
  99. 3:51October and then it crashed all the way
  100. 3:53to 250 right at the 200 day and then
  101. 3:54look at this V-shaped recovery. Like
  102. 3:56that is exactly what you want to see.
  103. 3:58One of our favorite setups is long-term
  104. 4:01winner and a short-term pullback that is
  105. 4:03now U-turning. It's exactly what you
  106. 4:05have here. Long-term winner, short-term
  107. 4:07pullback, now U-turning at the most
  108. 4:09important technical support level. And
  109. 4:11better yet, it's bouncing because of a
  110. 4:14strong fundamental catalyst with their
  111. 4:16recent earnings report last week that
  112. 4:18was absolutely fantastic.
  113. 4:21The caveat here is you're paying a crap
  114. 4:23ton for the stock, 163 times forward
  115. 4:26earnings, 106 times forward EBITDA. But
  116. 4:29as you can see on a two-year basis,
  117. 4:30that's actually below average on the PE
  118. 4:32multiple, a little bit below average on
  119. 4:34the EBITDA multiple. So I really don't
  120. 4:36think this one is like the valuation
  121. 4:37should be that much of a headwind. I
  122. 4:39really like Cloudflare here. I like the
  123. 4:41cyberspace. We talked about that
  124. 4:43previously, but we missed my favorite
  125. 4:44stock and that's Cloudflare. I think the
  126. 4:46entry point here on a bounce off the 200
  127. 4:48day is really attractive.
  128. 4:51>> Awesome. Yeah, I mean the the the
  129. 4:52valuations are almost the MO for these
  130. 4:55cybersecurity stocks. So I have about
  131. 4:56two kind of follow-ups here, Luke. One
  132. 4:59is almost tangential. So you mentioned
  133. 5:01the AI agents thing. So notably, I think
  134. 5:04Jamie Diamond
  135. 5:05banned the use of AI agents in online
  136. 5:08banking. Do you think that would be more
  137. 5:10pervasive in, you know, the broader
  138. 5:12market where companies are disallowing
  139. 5:15the use of agents?
  140. 5:16>> No, I think the use of agents is going
  141. 5:18to it's going to be enormous. I don't
  142. 5:19think these are like kind of one-off
  143. 5:21cases where it gets banned here, banned
  144. 5:22there. And where it gets banned, it's
  145. 5:24for the temporary pause. It's more of
  146. 5:25like let's think about how we're going
  147. 5:27to use them and then let's use them
  148. 5:28responsibly. Kind of like what's going
  149. 5:29on with the data center
  150. 5:31trade, right? It's not an outright
  151. 5:34stalling in capital expenditures for
  152. 5:37building new data centers, but it's now
  153. 5:38like, okay, let's sit back and think
  154. 5:40about how we can do this more
  155. 5:41responsibly.
  156. 5:42That's sort of how I viewed the agent
  157. 5:44trade, too. So I don't think the agent
  158. 5:46the growth of agents is a trend that's
  159. 5:48going to stop anytime soon.
  160. 5:50I think there may be pauses here and
  161. 5:51there, but the overall trend will be
  162. 5:52exponential growth in agentic traffic on
  163. 5:55the internet, and that is a exponential
  164. 5:57tailwind for a stock like Cloudflare.
  165. 6:00>> Of course, agreed. And then second, this
  166. 6:02is kind of a broader question for all of
  167. 6:04these stocks. So to clarify, this isn't
  168. 6:06a rotation out of our, you know, core AI
  169. 6:09trades. This is more of a broadening of
  170. 6:10our portfolio to kind of hedge it. Is
  171. 6:13that Is that right?
  172. 6:14>> Yeah, I [clears throat] would I would
  173. 6:15say that
  174. 6:17yes and no. We're in a very confusing
  175. 6:19period for the markets. We'll talk about
  176. 6:21it a lot more in the macro podcast
  177. 6:23coming up, but
  178. 6:24we're in a very confusing period where
  179. 6:27things could go either way. Um the
  180. 6:32the demand for AI is still amazing and
  181. 6:36sensational.
  182. 6:37And if that were the only thing that
  183. 6:40mattered, then the trade is very much
  184. 6:42alive and well. But it's not the only
  185. 6:44thing that matters. That Washington has
  186. 6:46entered the conversation. Wall Street
  187. 6:48has entered the conversation. Supply
  188. 6:50chain shortages have entered the
  189. 6:52conversation. And so these three
  190. 6:54non-demand related factors can put
  191. 6:57significant downward pressure on the
  192. 7:00data center trade, the AI data center
  193. 7:02trade in the short term.
  194. 7:04I I don't think it says anything about
  195. 7:05the 12 to 24 to 36 month outlook on
  196. 7:09these stocks, but it does say a lot
  197. 7:11about the uncertainty over the next
  198. 7:12three to six months. And I think it's
  199. 7:14very likely
  200. 7:16that we do see capital expenditures from
  201. 7:19the hyperscalers come in lower than
  202. 7:21expected for 2027 and 2028, lower than
  203. 7:25planned. And so if that happens, and for
  204. 7:28our previous podcast was, you got to
  205. 7:30fundamentally ask yourself the question,
  206. 7:31will the hyperscalers stop spending?
  207. 7:34Will they reduce their spending? If no,
  208. 7:37stay bullish. If yes, get cautious. In
  209. 7:40the last week, enough factors have
  210. 7:42changed for me. When I ask that question
  211. 7:45now, I have to say
  212. 7:47it won't slow,
  213. 7:50but it's probably not going to grow a
  214. 7:51whole bunch. And the problem with that
  215. 7:53is that the estimates price in
  216. 7:55hyperscaler CapEx growth into like 2030.
  217. 8:00And those estimates are probably wrong.
  218. 8:02We probably stay We'd probably get a big
  219. 8:03jump in 27 that's smaller than expected.
  220. 8:06And then 28, 29, 30 are probably stable
  221. 8:08levels of spending, which means those
  222. 8:10CAPEX estimates have to come down. And
  223. 8:12if the CAPEX estimates come down, that
  224. 8:14means the receiving end has to come down
  225. 8:16as well, the EPS estimates for the
  226. 8:18entire AI supply chain. So I think we're
  227. 8:20kind of due for downward revisions in a
  228. 8:22lot of those estimates, and that can put
  229. 8:24pressure on the trade in the short term.
  230. 8:26But we're going to find a steady state
  231. 8:28on the other end of that transition
  232. 8:29where it's like,
  233. 8:31okay, these earnings are still big. Now
  234. 8:33they're at a base. Now they can grow
  235. 8:35sustainably and the trade rebounds like
  236. 8:36crazy. I think we're going to get one of
  237. 8:37the best buying opportunities uh in the
  238. 8:39last 25 years in tech stocks in the next
  239. 8:43three months, but I don't think it's
  240. 8:44right now. So that's why we're focusing
  241. 8:46on sort of okay, the AI trade is, you
  242. 8:49know, put on hold, put on pause. It's in
  243. 8:50timeout. It's in the corner, that core
  244. 8:52data center trade. These are stocks that
  245. 8:54you can play in the meantime, in my
  246. 8:56opinion, while that data center trade is
  247. 8:58kind of in in the timeout zone.
  248. 9:01>> Definitely. And yeah, of course, we're
  249. 9:02going to dig into that more in the macro
  250. 9:04episode. Uh but next up, let's uh talk
  251. 9:06about JFrog. So they reported 31%
  252. 9:09revenue growth and their cloud revenue
  253. 9:11increased over 60%.
  254. 9:13>> Yeah, JFrog is a stud. JFrog is the
  255. 9:16exact type of stock you want to own in
  256. 9:17this environment because it's the type
  257. 9:19of stock that kind of like Cloudflare,
  258. 9:21but even more uh
  259. 9:23emphatically, has a ton of exposure to
  260. 9:26growth in AI adoption, but not a ton of
  261. 9:31exposure to AI CAPEX. So the data center
  262. 9:35build out can slow or stall or whatever
  263. 9:37word you want to use, and it won't
  264. 9:40impact JFrog because like I said, that
  265. 9:43slowdown is not demand driven. It's
  266. 9:45Washington driven, Wall Street driven,
  267. 9:46supply chain driven. Demand is still
  268. 9:49there. So if you have a non-demand
  269. 9:51driven slowdown, yes, that's going to
  270. 9:52hurt the supply chain companies, but
  271. 9:54it's not going to hurt the application
  272. 9:55layer. And JFrog is at that application
  273. 9:58layer. Really like
  274. 10:00every line the the
  275. 10:01400-ft bolt thesis here is that every
  276. 10:04line of code that an AI writes becomes a
  277. 10:09software file that has to be stored and
  278. 10:13secured and tracked. And that is
  279. 10:16JayFrog's whole business. They kind of
  280. 10:17create that software, if you will, that
  281. 10:21stores, secures, and tracks essentially
  282. 10:23every line of AI software code. So the
  283. 10:25idea is that more AI code, more demand
  284. 10:29for JayFrog, higher revenues, higher
  285. 10:31profits. And that's exactly what you saw
  286. 10:33in their in their earnings report. If
  287. 10:34you kind of pull up the numbers here, I
  288. 10:36mean, you you kind of named a few, but
  289. 10:38yeah, I mean, revenues are up 31%. Cloud
  290. 10:41revenue is 60% of sales. Contracted
  291. 10:44future revenue there, their RPO or
  292. 10:46remaining performance obligations up
  293. 10:4760%. Uh net retention of 124%, which is
  294. 10:51ridiculous. Gross retention of 97%.
  295. 10:54Uh they grew their number of big ticket
  296. 10:57customers, $1 million plus customers uh
  297. 10:59by 60% in the quarter, 58%. Uh the guide
  298. 11:03was way above expectations on both
  299. 11:05revenue and EPS. I mean, it was just
  300. 11:07like it was a fantastic report and the
  301. 11:08stock obviously soared like crazy. And
  302. 11:11if you look at the chart, like I said,
  303. 11:12we want to look for stocks that
  304. 11:15have been working in the chaos. Frog is
  305. 11:17a stock that has been working in the
  306. 11:19chaos. Look at that. It just it's
  307. 11:20sprinting to new highs. It was the stock
  308. 11:23that had this consolidation for a bit,
  309. 11:24dropped to the 200-day moving average,
  310. 11:26and is now blasting higher to new highs.
  311. 11:28That's that's fantastic to see. RSI is
  312. 11:31not overbought. It's right around just
  313. 11:33below 60. You got a bullish MACD
  314. 11:34crossover, you got great momentum. Uh
  315. 11:36the growth profile here is absolutely uh
  316. 11:40amazing when you look at uh the out-year
  317. 11:42estimates. And again, these estimates
  318. 11:44feel stable to me because it's tied to
  319. 11:46AI adoption, not AI CapEx. So you got
  320. 11:49basically compounded 20% revenue growth
  321. 11:51on the top line to an 80% plus gross
  322. 11:53margin business with stable EBITDA
  323. 11:55margins. You have 20% plus on the bottom
  324. 11:57line, and you're not paying all that
  325. 11:59much for it here. When you look at the
  326. 12:01valuation for that,
  327. 12:03you're only paying I mean, 81 times
  328. 12:05sounds like a lot, but on EBITDA you're
  329. 12:07paying 68.5 times. You're on the upper
  330. 12:10end of the valuation range, but it's
  331. 12:11really not super expensive for a high
  332. 12:13margin, high cash flow, high growth
  333. 12:17company tied to the biggest tailwind in
  334. 12:20the economy right now. So Jfrog to me is
  335. 12:22the exact type of stock that you want to
  336. 12:24own at this moment. I really like this
  337. 12:26one.
  338. 12:28>> Excellent.
  339. 12:28>> Yeah, love that.
  340. 12:29>> All right, so next up uh we're going
  341. 12:31into the biotech sector uh
  342. 12:33>> Mhm.
  343. 12:34>> relatively seasonal sector. Uh first up
  344. 12:36is Adaptive Biotechnologies, ADPT.
  345. 12:39>> Right. Right. So the the big picture
  346. 12:41both these is so biotech's been having a
  347. 12:42moment. Biotech stocks have been doing
  348. 12:44really well. Healthcare stocks have been
  349. 12:46doing really well. Again, the continuing
  350. 12:48this theme of looking for stocks that
  351. 12:50have done well in the chaos. Biotech and
  352. 12:52healthcare are the two sectors that have
  353. 12:53done really really well in the chaos.
  354. 12:55Now what Adaptive does is they own the
  355. 12:57leading tests for spotting the last
  356. 13:00traces of blood cancer after treatment.
  357. 13:02Uh medical guidelines are moving toward
  358. 13:04testing patients more often uh which
  359. 13:07should give the company years of steady
  360. 13:10profitable growth with no link again to
  361. 13:13this AI CapEx slowdown. So it's a
  362. 13:16company that has some AI driven
  363. 13:18tailwinds. They're using AI with a lot
  364. 13:20of that testing. They have an AI
  365. 13:21subdivision. Um the growth is is strong
  366. 13:25and it's independent of the capital
  367. 13:28spending trends uh or capital spending
  368. 13:30plans of the hyperscalers. Um their
  369. 13:33their main product is this this Clono
  370. 13:36SEQ they call it, which is a blood or
  371. 13:38bone marrow test for cancers like
  372. 13:39multiple myeloma, leukemia, and
  373. 13:42lymphoma. That
  374. 13:44test is growing very very very quickly.
  375. 13:47If we kind of pull up the numbers on
  376. 13:49their recent results here um
  377. 13:54yeah, I mean the the the number of those
  378. 13:56Clono SEQ tests was 39,587
  379. 14:00which is up 60 46%
  380. 14:03uh year over year. Massive growth there.
  381. 14:06And if you look at the growth that it's
  382. 14:07supposed to persist, look at the growth
  383. 14:09profile for ADPT
  384. 14:13going out to 2029. Let's pull up those
  385. 14:16estimates again. So, big growth. 22, 24,
  386. 14:2016, 18, call it compounded 20. Gross
  387. 14:23margin 74 up to 77. The most attractive
  388. 14:27thing about this is we're going to
  389. 14:28finish the year at 3% EBITDA margins.
  390. 14:30When you have a 20% plus top line grower
  391. 14:33with 70% plus gross margins that is only
  392. 14:36at 3% EBITDA margins, that either means
  393. 14:38one, the company is very poorly run, or
  394. 14:41two, there's a lot of room for operating
  395. 14:43leverage over the next several years.
  396. 14:45And that's exactly what I'm expecting
  397. 14:46here. EBITDA margins running from 3
  398. 14:48million or 3% rather 9 million to 29% in
  399. 14:52183 million dollars. This is one of the
  400. 14:54biggest EBITDA growth profiles in the
  401. 14:56market right now. Very attractive. Now
  402. 14:59the valuation is a little steep, but I
  403. 15:02don't think it's steep enough
  404. 15:03considering that growth profile. 108.4
  405. 15:06times EBITDA, but if you look over here
  406. 15:08and you see EBITDA gets up to 200
  407. 15:09million dollars, okay. 200 million
  408. 15:11dollars, a stock like this can trade at
  409. 15:13easily, you know, 40 50 times the
  410. 15:15earnings or EBITDA. 200 on 50 is 10
  411. 15:18billion. That's a double in like two or
  412. 15:20three years. So, this is a stock that I
  413. 15:22think the valuation has room to expand.
  414. 15:24I also think those out year estimates
  415. 15:27excuse [clears throat] me, move higher.
  416. 15:28And then you look at the chart
  417. 15:30and the chart again is just really
  418. 15:31attractive. What has been working? Look
  419. 15:33at this chart. This has been working.
  420. 15:35Great uptrend on the stock. Came into
  421. 15:37[snorts] its 100 day, bounced back into
  422. 15:39its 100 day, bounced, about to make a
  423. 15:40new high. Actually is at a new high.
  424. 15:43Maximum drawdown right now is 0 percent,
  425. 15:45so it did make a new high today. RSI is
  426. 15:48not overbought. MACD looks good.
  427. 15:50Momentum looks good. This is a winning
  428. 15:52stock. It's got upside. I think this is
  429. 15:55a a a good play amidst the recent chaos.
  430. 15:59>> Yeah, that's that's awesome. A blood
  431. 16:00test that actually works. Um so with
  432. 16:02>> actually works. There you go.
  433. 16:05>> So with uh with their MN their minimal
  434. 16:07residue residual disease testing, it's
  435. 16:10not currently routine. If it does become
  436. 16:13a routine part of cancer treatment, do
  437. 16:14we have an idea of what that TAM is, how
  438. 16:17much growth we can expect from that.
  439. 16:19>> that's why I think these estimates are
  440. 16:21low, right? I mean, I think you're the
  441. 16:22MRD business is
  442. 16:25working, but it's not
  443. 16:28I mean, it's the main engine of growth,
  444. 16:29but it could be a lot bigger than what
  445. 16:31it is today. And if that starts to
  446. 16:33really kick in, I don't think his
  447. 16:34estimates price that in. And so like I
  448. 16:36said, I use 200 million EBITDA. That's
  449. 16:38kind of like an exit goal for 2030. We
  450. 16:40could probably get to 300 or 400
  451. 16:42million. We probably double that. And
  452. 16:43then all of a sudden, you know, the
  453. 16:44valuation here can get really really
  454. 16:46big. So
  455. 16:47this is a stock that even on
  456. 16:48conservative estimates doesn't look
  457. 16:50overvalued right now. And if you get,
  458. 16:53you know, more aggressive estimates
  459. 16:54baked in there, it's a stock that could
  460. 16:56really fly. So I I really like this one.
  461. 16:58It's been on an uptrend for a while,
  462. 17:00right? If you look at the long-term
  463. 17:01chart, it really kind of bottomed in
  464. 17:02late 24 early 24 at around, you know,
  465. 17:05two bucks and change and now it's 30. So
  466. 17:0715 bagger if you want to look at it from
  467. 17:09that perspective. I just think this
  468. 17:11uptrend has a lot of runway. So this is
  469. 17:13a good company and it's a good stock.
  470. 17:15And so I think this is a good time to to
  471. 17:18play defense, if you will, with it.
  472. 17:21>> Awesome. Okay. So moving on to another
  473. 17:24company pretty similar or similar
  474. 17:26enough, Tempest AI, which is a true AI
  475. 17:29healthcare platform.
  476. 17:30>> Right. Yep. Yeah. I mean, so again,
  477. 17:32biotech healthcare, it's been working.
  478. 17:34So let's go with what's working. Tempest
  479. 17:36has been one of our favorite companies
  480. 17:38at the AI application layer for a very
  481. 17:40long time. It's in a very volatile
  482. 17:41stock, but it's starting to really have
  483. 17:43a moment in the market. What the
  484. 17:46company's done is they've essentially
  485. 17:47they're pioneering personalized AI
  486. 17:49medicine, which is this whole idea that
  487. 17:52with AI, we can personalize healthcare
  488. 17:54treatments to you
  489. 17:56and not just a general treatment, but a
  490. 17:58personalized treatment to you. And
  491. 18:00obviously the the fuel of that and what
  492. 18:04determines how
  493. 18:06the efficacy of a personalized AI
  494. 18:08healthcare treatment plan is going to be
  495. 18:11the underlying data. And Tempest has
  496. 18:14built one of the largest collections of
  497. 18:16patient data in the entire medical
  498. 18:19industry. And they are leveraging that
  499. 18:21data to create very robust AI algorithms
  500. 18:23and then partnering with very large
  501. 18:25healthcare firms to pioneer personalized
  502. 18:28AI healthcare treatments. And so this is
  503. 18:31a company that again I think is they're
  504. 18:32in the early innings of a massive
  505. 18:34massive growth burst. Uh they just
  506. 18:37reported earnings what was like a week
  507. 18:38or two ago. Really good numbers. We can
  508. 18:41pull those up here.
  509. 18:43Revenue was up 23% year over year. Uh
  510. 18:46their cancer test volume was up 32%
  511. 18:48their data and AI revenue was up 33%
  512. 18:52adjusted EBITDA jumped from 1.5 million
  513. 18:54to 25.6
  514. 18:57uh million. Really just absolutely
  515. 19:00crushing it. Uh
  516. 19:02bookings guidance was strong. Revenue
  517. 19:04guidance was strong.
  518. 19:05You look at the growth profile here. 26%
  519. 19:08this year on the top line 24 21 2017
  520. 19:12no AI CAPEX exposure here. Those
  521. 19:16estimates can probably drift higher.
  522. 19:19Very similar situation as you have with
  523. 19:21ADT ADPT where you have a high gross
  524. 19:23margin business that one was 70% plus
  525. 19:25this one is 65% plus inching towards 70
  526. 19:28trading at a low single digit uh EBITDA
  527. 19:31margin
  528. 19:32EBITDA margin right now 4%. So that can
  529. 19:35you know through operating leverage get
  530. 19:37from 4 to 24 and EBITDA goes from 65 to
  531. 19:40800 million. And I think actually I
  532. 19:42think 2030 EBITDA could look more like a
  533. 19:44billion.
  534. 19:45And again stock like this high growth
  535. 19:47high margin high cash flow biotech
  536. 19:49company uh healthcare technology company
  537. 19:52whatever you want to call it uh can
  538. 19:54trade at you know 40x earnings or 40x
  539. 19:56EBITDA pretty easily. So if this gets to
  540. 19:58a billy
  541. 19:59by 2030 you put 40 on it that's 40 billy
  542. 20:02and we're at 15 billion now. So that's a
  543. 20:04lot of upside in the next three years.
  544. 20:06And so I think this one has a lot of
  545. 20:08fundamental driven upside. And then when
  546. 20:10you look at the chart it's really
  547. 20:11starting to flash some breakout signals
  548. 20:13to me. You know Tempest AI like I said
  549. 20:16it's been a volatile stock. It's kind of
  550. 20:18gone it's yo-yoed quite a bit but right
  551. 20:20now it's yo-yoing up. And I think that
  552. 20:22yo-yo up has has runway. You can see
  553. 20:24again I kind of want to just show the
  554. 20:25volatility in this name.
  555. 20:27Uh it's been very volatile for a while.
  556. 20:30Had that big run in 25 and then gave it
  557. 20:33all back pretty much and now we're
  558. 20:34having another big run. The fact that
  559. 20:37we're breaking above there's this big
  560. 20:38peak right here right around what is
  561. 20:40that? 72 we crushed through that. Had
  562. 20:43this big peak around 77 crushed through
  563. 20:45that. So the fact that we're crushing
  564. 20:47these previous peaks tells me we're at
  565. 20:49least getting to 90 you know this high
  566. 20:51from February and then some highs back
  567. 20:53here in in September. We're going to at
  568. 20:55least get the 90 on this one and I think
  569. 20:56we're actually getting the cycle turn
  570. 20:59you know the 50 above the 100 above the
  571. 21:01200 200 slope now turning higher. This
  572. 21:04looks like a pretty big turn and so I
  573. 21:06think we make a push for all time highs
  574. 21:08and that all time high was uh October
  575. 21:102025 around 103 I think we get above
  576. 21:13that to 110. So I think in the short
  577. 21:14term we got pretty good upside here and
  578. 21:16the long term fundamentals also look
  579. 21:17great so Tempest stock has my stamp of
  580. 21:20approval in this current market.
  581. 21:22>> [snorts]
  582. 21:22>> That's awesome. Is there a conflict of
  583. 21:24interest between Tempest and ADPT like
  584. 21:27uh with its you know kind of data moat?
  585. 21:29Would it essentially eat ADPT's lunch in
  586. 21:31the the future if its models keep
  587. 21:33growing?
  588. 21:34>> Conflict of interest I I mean I don't
  589. 21:37know if it's conflict of interest. They
  590. 21:38they are they are competitive in a very
  591. 21:41growing market but it's kind of like AMD
  592. 21:42and Nvidia. Uh it's kind of like a
  593. 21:45recent networks and momentum it's kind
  594. 21:47of like there's just there's a lot of
  595. 21:49growth in this area uh of the biotech
  596. 21:52world you know using AI to improve
  597. 21:54clinical outcomes and I do think
  598. 21:57healthcare outcomes and patient outcomes
  599. 21:59and I do think the Tempest and ADPT and
  600. 22:01then some others out there can succeed
  601. 22:03side by side. They're not going to be
  602. 22:05rubbing elbows. There's a lot of green
  603. 22:06space in this patch a lot of opens uh
  604. 22:08space in this past year and so I don't
  605. 22:10think they're going to be rubbing elbows
  606. 22:11for a very very long time.
  607. 22:14>> Roger that. Okay uh last but certainly
  608. 22:16not least the healthcare giant Eli Lily
  609. 22:20uh LLY.
  610. 22:22>> Yeah I mean Lily so the the growth
  611. 22:25engine of the market in the last three
  612. 22:28years has been two really.
  613. 22:31One, AI, and then number two by a wide
  614. 22:34margin, you know, big distance, but
  615. 22:36there was a number two and that was
  616. 22:37GLPs, right? That was the weight loss
  617. 22:39stuff.
  618. 22:39>> Of course.
  619. 22:40>> And these guys are just absolutely
  620. 22:42crushing it there. I mean Mounjaro,
  621. 22:45Zepbound, these GLP-1 style drugs are
  622. 22:51all the rage. They're moving into pill
  623. 22:53form. Um the uh what do they call it?
  624. 22:56Foundeo, right? Foundeo is a daily
  625. 22:58weight loss pill they just launched. Uh
  626. 23:00and I think with that the growth runway,
  627. 23:03everybody was doubting the growth runway
  628. 23:05for the GLP ones, right? Everyone's
  629. 23:06like, okay, everyone got the shot, now
  630. 23:07what? Well, the growth runway extends
  631. 23:09dramatically with the pill. There are so
  632. 23:11many people out there that just will not
  633. 23:12take a shot, but you make a weight loss
  634. 23:15an effective weight loss pill and all of
  635. 23:17a sudden you increase the market by a
  636. 23:20dramatic amount. And so I think there's
  637. 23:22just really big growth here yet to come
  638. 23:25that is not priced into the stock
  639. 23:26because of the runway extension of the
  640. 23:28pill. Um Eli Lilly, you look at the
  641. 23:31growth profile. See, here's here's the
  642. 23:33thing I like about the stock. You have
  643. 23:35this dramatic slowdown priced in.
  644. 23:38Revenue's up 40% this year and then 16,
  645. 23:4012, 9, 7. That's a massive deceleration
  646. 23:44when this was a 45, 46, 40% growth
  647. 23:47company. Now you're going to get into
  648. 23:49mid teens all the way down to single
  649. 23:50digits? I don't think so. I think the
  650. 23:52pill keeps us above 15 if not above 20
  651. 23:56for the next two to three years. So
  652. 23:57these estimates got to move higher. They
  653. 24:00will move higher, which means the margin
  654. 24:02estimates are going to move higher
  655. 24:04because look at this. You're at 46%
  656. 24:05EBITDA today going up to 57. Maybe
  657. 24:08you're 46 to 67. So all of a sudden you
  658. 24:11get a you know, a 20% uplift on 2030
  659. 24:14revenues and you add 10 points of margin
  660. 24:16expansion, you get a 30 40% uplift on
  661. 24:19EBITDA estimates. And so I think there's
  662. 24:20a huge uplift to come on those EBITDA
  663. 24:23estimates. And when you look at the
  664. 24:24valuation, it's just again, it's not
  665. 24:26priced for accelerating growth not
  666. 24:29accelerating growth, but for stable and
  667. 24:31high growth. You look at that. I mean,
  668. 24:3229 times forward earnings is essentially
  669. 24:35a five year low. 24 times forward P/E is
  670. 24:38essentially a five year low. So we're
  671. 24:41trading it near five year low valuations
  672. 24:43on the assumption that growth is going
  673. 24:44to slow because GLP 1s have run their
  674. 24:46course, and I just don't think they
  675. 24:48have. I think that that pill is going to
  676. 24:50really extend the market and the sales
  677. 24:53runway here
  678. 24:54by a lot more than what the street is
  679. 24:55expecting and pricing in. And the stock,
  680. 24:57again, what has been working, oh, hey,
  681. 25:00look, this has been working.
  682. 25:02Really strong. 1,400 here, boom,
  683. 25:05bursting right through it, setting new
  684. 25:06highs.
  685. 25:07Things look good here. So I think this
  686. 25:09is a great stock and it's a great
  687. 25:10company. I think it's a great stock to
  688. 25:12hide in or play defense with amidst the
  689. 25:15recent market turmoil.
  690. 25:17>> Yeah, excellent.
  691. 25:19So with
  692. 25:21Eli Lily, the GLP essentially made it a
  693. 25:23a trillion dollar company.
  694. 25:26Do we have a fear of GLP 1s running
  695. 25:29their course? I know you mentioned that
  696. 25:30just a just a moment ago, but is there a
  697. 25:33concern of that in the future once maybe
  698. 25:35the market is saturated with them?
  699. 25:38>> Yeah.
  700. 25:40But I think we're years away from that.
  701. 25:42Again, I mean, let just put it here. The
  702. 25:44the estimates price in saturation
  703. 25:47happening too soon.
  704. 25:49So if we push out that saturation point
  705. 25:51because the pill outperforms, which I
  706. 25:53think it will, then estimates move
  707. 25:55higher on a low valuation and the stock
  708. 25:57works. Like I think it's it's that
  709. 25:59simple. So this fear of like when it
  710. 26:01becomes saturated, like yeah, we'll deal
  711. 26:03with that when we get close to that. But
  712. 26:05I don't think we're close to that.
  713. 26:08>> Excellent. Okay.
  714. 26:10Um
  715. 26:11I guess my question here is we we we
  716. 26:12touched on, you know, two different
  717. 26:14sectors really. So which which of these
  718. 26:16stocks do you think offers kind of the
  719. 26:18best risk adjusted return over the next
  720. 26:20three to five years? Are we are we
  721. 26:21looking at the the
  722. 26:23the AI software layer or the healthcare
  723. 26:25layer?
  724. 26:27>> Uh
  725. 26:29if you're talking about the next
  726. 26:31Again, it depends on on time frame.
  727. 26:33These stocks I'm highlighting as I think
  728. 26:36great stocks for the next 3 to 6 months.
  729. 26:40I think there's long-term
  730. 26:42growth potential here too. But I think
  731. 26:44in the next 3 to 6 months, these stocks
  732. 26:46outperform your AI data center stocks.
  733. 26:49Then I think in the next 3 to 5 years,
  734. 26:51the AI data center stocks actually kick
  735. 26:53these stocks ass. Like that's that's
  736. 26:55what I really believe because I think
  737. 26:57the trade, the AI data center trade is
  738. 27:00transitioning, not ending. The
  739. 27:02transition is painful and it may not be
  740. 27:05over. Maybe more shoes to drop if you
  741. 27:07will, more legs lower if you will. But
  742. 27:10eventually we are going to bottom and
  743. 27:12when we do bottom, I think it's going to
  744. 27:14be a massive rebound rally on the other
  745. 27:15side as the market adjusts to the new
  746. 27:17normal of stable but still high capital
  747. 27:21spending plans from the hyperscalers and
  748. 27:23stable but still high EPS estimates
  749. 27:25across the AI supply chain and then
  750. 27:27boom, we rebound like crazy. So I think
  751. 27:30in a 3 to 5 year window, data center
  752. 27:32stocks and a 3 to 6 month window, the
  753. 27:35application layer is starting to look
  754. 27:37really good. Healthcare looks really
  755. 27:39good. Biotech looks really good. I'm not
  756. 27:41going to go and chase the consumer
  757. 27:42staples trading at 30 times earnings for
  758. 27:442% growth. That makes no sense. There
  759. 27:46are a lot out there right now.
  760. 27:50I wouldn't chase that. I wouldn't play
  761. 27:51defense there. I would still play
  762. 27:52offense but I would play offense away
  763. 27:55from the the core data center trade
  764. 27:58until that really starts to stabilize.
  765. 28:01>> Okay. I think that's a great place to
  766. 28:03wrap the episode. As always, appreciate
  767. 28:04the insight, Luke. And we'd like to
  768. 28:06thank you for tuning in as well. Please
  769. 28:08make sure to like, comment and subscribe
  770. 28:10so we can keep the channel going and
  771. 28:11flowing. That's being exponential.
  772. 28:14Signing off.
  773. 28:19>> [music]

About this transcript

This page contains the full transcript of The AI Trade Isn't Dead (Here Are 5 Stocks to Buy) by Being Exponential with Luke Lango, generated from the public captions YouTube serves with the video. The transcript has 5,224 words across 773 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.